Mangoceuticals Stock Quote MGRX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.4251

Bid

0.419

Ask

0.43

Volume

2,117,029

0.4051 Day's Range 0.454

0.143 52 Week Range 1.5899

Market Cap

10.551M

Previous Close

0.42

Open

0.4224

Last Trade

0.43

Last Trade Time

Financial Volume

$ 913,483

VWAP

0.431493

Average Volume (3m)

6,107,997

Shares Outstanding

24,819,500

Dividend Yield

PE Ratio

-1.16

Earnings Per Share (EPS)

-0.37

Revenue

731k

Net Profit

-9.21M

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was i... Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. Show more

Sector

Health & Allied Services,nec

Industry

Health & Allied Services,nec

Website

www.mangorx.com

Headquarters

Dallas, Texas, USA

Founded

1970

Mangoceuticals Inc is listed in the Health & Allied Services sector of the NASDAQ with ticker MGRX. The last closing price for Mangoceuticals was $0.42. Over the last year, Mangoceuticals shares have traded in a share price range of $ 0.143 to $ 1.5899.

Mangoceuticals currently has 24,819,500 shares outstanding. The market capitalization of Mangoceuticals is $10.42 million. Mangoceuticals has a price to earnings ratio (PE ratio) of -1.16.

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s health and wellness products including erectile dysfunction...

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

DALLAS, TEXAS, July 18, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

DALLAS, TX, July 16, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

DALLAS, TEXAS, July 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

DALLAS, TEXAS, July 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men’s...

Form 144 - Report of proposed sale of securities

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0271	6.80904522613	0.398	0.465	0.35	569361	0.40657127	CS
4	0.1031	32.0186335404	0.322	0.47	0.294059	1697372	0.38619232	CS
12	0.1651	63.5	0.26	1.12	0.2128	6107997	0.48220548	CS
26	0.1131	36.25	0.312	1.12	0.143	3240846	0.45261339	CS
52	-0.7749	-64.575	1.2	1.5899	0.143	1792199	0.46433161	CS
156	-3.7749	-89.8785714286	4.2	4.2694	0.143	1934258	0.80162001	CS
260	-3.7749	-89.8785714286	4.2	4.2694	0.143	1934258	0.80162001	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.45M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M